Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
US Department of Health and Human Services, Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority, National Institute of Allergy and Infectious Diseases, and National Institutes of Health.
Authors
- Rebecca Maguire (ORCID: https://orcid.org/0000-0002-0368-4626)
- David B. Musante
- Karen L. Kotloff (ORCID: https://orcid.org/0000-0003-1808-6431)
- Stephanie J. Schrag (ORCID: https://orcid.org/0000-0002-8113-2544)
- Elizabeth Formentini
- Rekha R. Rapaka (ORCID: https://orcid.org/0000-0002-4770-4422)
- Kathleen M. Neuzil (ORCID: https://orcid.org/0000-0001-9480-2714)
- Robín Masón (ORCID: https://orcid.org/0000-0003-3143-6811)
- Jacques Ravel (ORCID: https://orcid.org/0000-0002-0851-2233)
- Meagan E. Deming (ORCID: https://orcid.org/0000-0003-2574-0542)
- Mike Humphrys
- Melissa Arvay (ORCID: https://orcid.org/0000-0003-3502-4259)
- Merlin L. Robb (ORCID: https://orcid.org/0000-0003-3949-9649)
- Jeffrey Adelglass
- Elizabeth R. Brown (ORCID: https://orcid.org/0000-0003-4286-2111)
- Monica A. McArthur (ORCID: https://orcid.org/0000-0003-2605-3752)
- P. A. Wolff
- Richard L. Gorman
- Brandon Essink (ORCID: https://orcid.org/0000-0002-7309-228X)
Institutions
- University of Maryland, Baltimore (US)
- Henry M. Jackson Foundation (US)
- National Center for Immunization and Respiratory Diseases (US)
- Biomedical Advanced Research and Development Authority (US)
- Fred Hutch Cancer Center (US)
- Plano Cancer Institute (US)
- National Institute of Allergy and Infectious Diseases (US)
- Durham VA Medical Center (US)
- Meridian Clinical Research (US)
Publication Details
- Journal
- The Lancet Microbe
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.lanmic.2024.100984
- Citations
- 4
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 5.58
Funders
- U.S. Department of Defense
- U.S. Department of Health and Human Services
- Pfizer
- University of Maryland
- Novavax
- National Institutes of Health
- Biomedical Advanced Research and Development Authority
- National Institute of Allergy and Infectious Diseases